Related Experiment Video
Updated: Jan 13, 2026

09:22
Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles
Published on: October 13, 2017
12.3K
Tear Fluid Inflammatory Factor Profile in Patients with HLA-B27-Associated Uveitis
Sara Rizvi1, Swaminathan Sethu2, Aneena Anna Thomas1
1Department of Uveitis and Ocular Immunology Services, Narayana Nethralaya, Bengaluru, India.
Ocular Immunology and Inflammation
|January 9, 2026
Summary
Elevated Interleukin (IL)-17A and Matrix Metalloproteinase 9 (MMP9) levels in tear fluid indicate their role in Human Leukocyte Antigen (HLA)-B27-associated uveitis inflammation. These findings suggest IL-17A and MMP9 as potential therapeutic targets.
Area of Science:
- Ophthalmology
- Immunology
- Biochemistry
Background:
- Human Leukocyte Antigen (HLA)-B27-associated uveitis is an inflammatory eye condition.
- Understanding the immunopathogenic mechanisms is crucial for effective treatment.
Purpose of the Study:
- To evaluate inflammatory factors in tear fluid of patients with HLA-B27-associated uveitis.
- To elucidate underlying immunopathogenic mechanisms.
- To identify potential biomarkers for therapeutic targeting.
Main Methods:
- Tear fluid was collected from 18 patients with HLA-B27-associated uveitis and 23 healthy controls.
- Levels of Interleukin (IL)-1β, IL-6, IL-17A, IL-10, Tumour Necrosis Factor alpha (TNFα), Matrix Metalloproteinase 9 (MMP9), Intercellular Adhesion Molecule 1 (ICAM1), and Vascular Endothelial Growth Factor-A (VEGF-A) were measured using multiplex ELISA.
Main Results:
- Tear fluid levels of IL-17A and MMP9 were significantly elevated in active uveitis eyes compared to controls.
- IL-17A levels were also higher in eyes with multiple uveitis episodes.
- Specific correlations between cytokines and ICAM-1 were observed predominantly in uveitic eyes.
Conclusions:
- Elevated IL-17A and MMP9 levels suggest their significant role in the inflammatory process of HLA-B27-associated uveitis.
- These cytokines represent potential novel therapeutic targets for managing this condition.

